Fresenius SE Total Assets 2016-2026 | FSNUY
Fresenius SE total assets from 2016 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Fresenius SE total assets for the quarter ending March 31, 2026 were $49.590B, a 8.94% increase year-over-year.
- Fresenius SE total assets for 2025 were $46.834B, a 0.62% decline from 2024.
- Fresenius SE total assets for 2024 were $47.125B, a 3.85% decline from 2023.
- Fresenius SE total assets for 2023 were $49.011B, a 39.13% decline from 2022.
|
Fresenius SE Annual Total Assets (Millions of US $) |
|
|---|---|
| 2025 | $46,834 |
| 2024 | $47,125 |
| 2023 | $49,011 |
| 2022 | $80,511 |
| 2021 | $85,138 |
| 2020 | $76,130 |
| 2019 | $75,047 |
| 2018 | $66,966 |
| 2017 | $60,056 |
| 2016 | $51,398 |
| 2015 | $47,936 |
|
Fresenius SE Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2026-03-31 | $49,590 |
| 2025-12-31 | $46,834 |
| 2025-09-30 | $49,631 |
| 2025-06-30 | $46,906 |
| 2025-03-31 | $45,519 |
| 2024-12-31 | $47,125 |
| 2024-09-30 | $46,588 |
| 2024-06-30 | $46,859 |
| 2024-03-31 | $48,078 |
| 2023-12-31 | $49,011 |
| 2023-09-30 | $81,987 |
| 2023-06-30 | $83,321 |
| 2023-03-31 | $82,172 |
| 2022-12-31 | $80,511 |
| 2022-09-30 | $80,906 |
| 2022-06-30 | $80,998 |
| 2022-03-31 | $82,049 |
| 2021-12-31 | $85,138 |
| 2021-09-30 | $83,819 |
| 2021-06-30 | $83,927 |
| 2021-03-31 | $83,145 |
| 2020-12-31 | $76,130 |
| 2020-09-30 | $79,867 |
| 2020-06-30 | $76,586 |
| 2020-03-31 | $76,090 |
| 2019-12-31 | $75,047 |
| 2019-09-30 | $74,236 |
| 2019-06-30 | $72,980 |
| 2019-03-31 | $73,810 |
| 2018-12-31 | $66,966 |
| 2018-09-30 | $64,789 |
| 2018-06-30 | $65,572 |
| 2018-03-31 | $65,765 |
| 2017-12-31 | $60,056 |
| 2017-09-30 | $62,405 |
| 2017-06-30 | $58,181 |
| 2017-03-31 | $57,993 |
| 2016-12-31 | $51,398 |
| 2016-09-30 | $48,773 |
| 2016-06-30 | $49,500 |
| 2016-03-31 | $46,825 |
| 2015-12-31 | $47,936 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $29.514B | $25.873B |
| Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |